Computerized Cognitive Assessment Products
Neurocognitive Screening for ADHD, Memory Loss, Alzheimer’s, Dementia, Traumatic Brain Injury
Since our last report in 2011, the market for computerized cognitive assessment, screening and testing has continued to expand. Key drivers for this market and growing technology product base include:
An Aging Global Population: 500 million people in the world today are older than 65. Dementia rates begin to rise sharply in this group after age 75.
Increased Awareness of Cognitive Health Issues: Rising rates of ADHD, Autism Spectrum Disorder, and sports concussions require standardized cognitive screening tools to help with diagnosis and treatment.
Advances in Technology Platforms: Portable cognitive screening is being enabled by tablet devices and internet access.
MyBrainTest has identified and researched cognitive health screening tools for ADHD, Alzheimer’s disease, short term memory loss, concussion, and traumatic brain injury (TBI) that can be administered in the physician’s office and other general use settings. Over twelve companies and cognitive assessment testing products are included in this report:
Representative companies and products include Cambridge Cognition (CANTABmobile), CNS Vital Signs, CogState (COGNIGRAM), HeadMinder, Medical Care Corp (MCI Screen), MedInteract (COGselftest), NeuroTrax (MindStreams), Psychology Software Tools (CAMCI), Screen Inc (CANS-MCI), Brain Resource (WebNeuro), BrainFx, US Department of Defense, imPACT Applications.
Download Report Executive Summary
Right-click and choose “Save as” for local copy
Purchase Single Report: $229
Purchase Team/Group Report (5 copies + PDF): $1295
Payment will appear as “Word Automation – MyBrainTest” on your statement.